| II-29 Brian Cicali Long-acting formulation drug-drug interactions: evaluating the importance of timing using a subcutaneous levonorgestrel PBPK example Wednesday 15:35-17:00 |
| II-29 Brian Cicali Long-acting formulation drug-drug interactions: evaluating the importance of timing using a subcutaneous levonorgestrel PBPK example Wednesday 15:35-17:00 |